Celadon Pharmaceuticals (CEL) Stock Chart & Stock Price History GBX 15 -1.50 (-9.09%) (As of 12/20/2024 11:48 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Celadon Pharmaceuticals Stock Price Performance 5 Day Performance-20.84%1 Month Performance+9.09%3 Month Performance-57.75%6 Month Performance-80.00%Year-To-Date Performance-86.96%1 Year Performance-87.50% Receive CEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Buy this coin BEFORE Inauguration Day … (Ad)Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. CEL Stock Chart for Saturday, December, 21, 2024 CEL Chart by TradingView Celadon Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 17GBX 15-11.76%GBX 19GBX 1545,837 shs£10.33 million12/19/2024GBX 17.48GBX 17-2.75%GBX 18GBX 16.2537,890 shs£11.70 million12/18/2024GBX 21GBX 17.48-16.76%GBX 21GBX 1717,496 shs£12.04 million12/17/2024GBX 18.95GBX 21+10.82%GBX 21GBX 1715,785 shs£14.46 million12/16/2024GBX 19GBX 18.95-0.26%GBX 20.80GBX 17.5040,828 shs£13.05 million12/13/2024GBX 19GBX 21+10.53%GBX 21GBX 19.4415,907 shs£14.46 million Get the Latest News and Ratings for CEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 21GBX 19-9.52%GBX 21GBX 17131,321 shs£13.08 million12/11/2024GBX 19GBX 21+10.53%GBX 21GBX 1749,646 shs£14.46 million12/10/2024GBX 19.88GBX 19-4.40%GBX 21GBX 1730,831 shs£13.08 million12/09/2024GBX 17.60GBX 19.88+12.93%GBX 19.88GBX 16102,326 shs£13.68 million12/06/2024GBX 16.90GBX 17.60+4.14%GBX 21GBX 1692,672 shs£12.12 million12/05/2024GBX 11GBX 16.90+53.64%GBX 17GBX 12306,797 shs£11.64 million12/04/2024GBX 12.50GBX 11-12.00%GBX 14GBX 1113,223 shs£7.57 million12/03/2024GBX 12.50GBX 12.50GBX 14GBX 11.3310,185 shs£8.61 million12/02/2024GBX 12.50GBX 12.50GBX 13GBX 128,805 shs£8.61 million11/29/2024GBX 13GBX 12.66-2.62%GBX 13GBX 12.0649,761 shs£8.72 million11/28/2024GBX 12.70GBX 13+2.36%GBX 13GBX 12.103,386 shs£8.95 million11/27/2024GBX 12.70GBX 12.70GBX 13GBX 128,048 shs£8.74 million11/26/2024GBX 13GBX 12.70-2.31%GBX 14GBX 12116,793 shs£8.74 million11/25/2024GBX 12.50GBX 13+4.00%GBX 14GBX 1324,529 shs£8.95 million11/22/2024GBX 13.75GBX 12.86-6.47%GBX 13.25GBX 12.7047,130 shs£8.85 million11/21/2024GBX 15.50GBX 13.75-11.29%GBX 16.30GBX 12.10332,250 shs£9.47 million11/20/2024GBX 18.40GBX 15.50-15.76%GBX 19GBX 15.2067,711 shs£10.67 million Related Companies Cambridge Nutritional Sciences Stock Chart Beacon Energy Stock Chart Curzon Energy Stock Chart Vodafone Group Public Stock Chart BT Group Stock Chart BBGI Global Infrastructure Stock Chart Pacific Horizon Investment Trust Stock Chart ECO Animal Health Group Stock Chart Shield Therapeutics Stock Chart Provexis Stock Chart Receive CEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CEL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celadon Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Celadon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
